Filing Details

Accession Number:
0001181431-10-062272
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-16 17:31:20
Reporting Period:
2010-12-14
Filing Date:
2010-12-16
Accepted Time:
2010-12-16 17:31:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1488364 Carl Severinghaus C/O Vermillion,Inc. 12117 Bee Caves Road
Building Two, Suite 100
Austin TX 78738
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-14 2,500 $6.00 15,000 No 4 S Direct
Common Stock Disposition 2010-12-15 3,500 $5.45 11,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The proceeds of the sale of the 6,000 shares of common stock described in this form are intended to cover the tax liability incurred by Carl Severinghaus on the 17,500 shares distributed to him on December 8, 2010.